- Home
- MRK vs ABT Comparison
MRK vs ABT Comparison
Compare MRK & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- ABT
- Stock Information
- Founded
- MRK 2000
- ABT 1888
- Country
- MRK United States
- ABT United States
- Employees
- MRK N/A
- ABT N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- ABT Medical/Dental Instruments
- Sector
- MRK Health Care
- ABT Health Care
- Exchange
- MRK Nasdaq
- ABT Nasdaq
- Market Cap
- MRK 198.5B
- ABT 237.4B
- IPO Year
- MRK N/A
- ABT N/A
- Fundamental
- Price
- MRK $80.44
- ABT $132.83
- Analyst Decision
- MRK Buy
- ABT Strong Buy
- Analyst Count
- MRK 15
- ABT 19
- Target Price
- MRK $111.14
- ABT $142.79
- AVG Volume (30 Days)
- MRK 12.4M
- ABT 7.8M
- Earning Date
- MRK 07-29-2025
- ABT 07-17-2025
- Dividend Yield
- MRK 4.03%
- ABT 1.79%
- EPS Growth
- MRK 20.41
- ABT 151.50
- EPS
- MRK 6.49
- ABT 7.97
- Revenue
- MRK $63,616,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- MRK $2.27
- ABT $7.60
- Revenue Next Year
- MRK $5.68
- ABT $7.84
- P/E Ratio
- MRK $12.39
- ABT $16.57
- Revenue Growth
- MRK 1.82
- ABT 5.85
- 52 Week Low
- MRK $73.31
- ABT $107.11
- 52 Week High
- MRK $120.30
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- MRK 48.77
- ABT 57.74
- Support Level
- MRK $78.65
- ABT $125.47
- Resistance Level
- MRK $81.32
- ABT $129.70
- Average True Range (ATR)
- MRK 2.11
- ABT 2.17
- MACD
- MRK -0.29
- ABT 0.86
- Stochastic Oscillator
- MRK 47.20
- ABT 93.93
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.